Clinical Trial

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

Recruiting
View on ClinicalTrials.gov →
Summary
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Trial Details
NCT Number NCT06953622
Lead Sponsor Peking University Third Hospital
Conditions Migraine, Patent Foramen Ovale
Enrollment 330 participants
Start Date 2024-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-01